Acorda Therapeutics
Stock Forecast, Prediction & Price Target
Acorda Therapeutics Financial Estimates
Acorda Therapeutics Revenue Estimates
Acorda Therapeutics EBITDA Estimates
Acorda Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $129.07M N/A | $118.56M -8.13% | $117.63M -0.78% | Avg: $163.09M Low: $163.09M High: $163.09M avg. 38.64% | |||
Net Income
% change YoY
| $-103.95M N/A | $-65.91M 36.59% | $-252.85M -283.60% | Avg: $-42.47M Low: $-42.47M High: $-42.47M avg. 83.20% | |||
EBITDA
% change YoY
| $-44.79M N/A | $-10.03M 77.60% | $8.40M 183.76% | Avg: $-18.78M Low: $-18.78M High: $-18.78M avg. -323.62% | |||
EPS
% change YoY
| -$195.75 N/A | -$66.9 65.82% | -$203.59 -204.31% | Avg: -$34.2 Low: -$34.2 High: -$34.2 avg. 83.20% | |||
Operating Expenses
% change YoY
| $165.58M N/A | $130.27M -21.32% | $94.85M -27.18% | Avg: $150.77M Low: $150.77M High: $150.77M avg. 58.95% | |||
FAQ
What is Acorda Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 83.20% in 2025-2025.
We have gathered data from N/A analysts. Their low estimate is -42.47M, average is -42.47M and high is -42.47M.
What is Acorda Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 38.64% in 2025-2025.
We have gathered data from 1 analysts. Their low revenue estimate is $163.09M, average is $163.09M and high is $163.09M.
What is Acorda Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 83.20% in 2025-2025.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$34.2, average is -$34.2 and high is $-34.2.